vs
Side-by-side financial comparison of Stoke Therapeutics, Inc. (STOK) and ZIPRECRUITER, INC. (ZIP). Click either name above to swap in a different company.
Stoke Therapeutics, Inc. is the larger business by last-quarter revenue ($158.6M vs $111.7M, roughly 1.4× ZIPRECRUITER, INC.). Stoke Therapeutics, Inc. runs the higher net margin — 71.2% vs -0.7%, a 71.9% gap on every dollar of revenue. On growth, Stoke Therapeutics, Inc. posted the faster year-over-year revenue change (3661.1% vs 0.6%). Stoke Therapeutics, Inc. produced more free cash flow last quarter ($131.7M vs $7.6M).
Stoke Therapeutics, Inc. is a clinical-stage biotechnology company developing innovative RNA-targeted therapies for severe rare genetic diseases. Its lead candidates address unmet needs for Dravet syndrome, a rare epilepsy, and other neurological monogenic disorders, serving patients across North America and global markets.
ZipRecruiter, Inc. is an American employment marketplace for job seekers and employers.
STOK vs ZIP — Head-to-Head
Income Statement — Q1 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $158.6M | $111.7M |
| Net Profit | $112.9M | $-835.0K |
| Gross Margin | — | 89.1% |
| Operating Margin | 70.2% | 3.6% |
| Net Margin | 71.2% | -0.7% |
| Revenue YoY | 3661.1% | 0.6% |
| Net Profit YoY | 528.0% | 92.3% |
| EPS (diluted) | $1.90 | $-0.03 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $111.7M | ||
| Q3 25 | — | $115.0M | ||
| Q2 25 | — | $112.2M | ||
| Q1 25 | $158.6M | $110.1M | ||
| Q4 24 | $22.6M | $111.0M | ||
| Q3 24 | — | $117.1M | ||
| Q2 24 | — | $123.7M | ||
| Q1 24 | — | $122.2M |
| Q4 25 | — | $-835.0K | ||
| Q3 25 | — | $-9.8M | ||
| Q2 25 | — | $-9.5M | ||
| Q1 25 | $112.9M | $-12.8M | ||
| Q4 24 | $-10.5M | $-10.8M | ||
| Q3 24 | — | $-2.6M | ||
| Q2 24 | — | $7.0M | ||
| Q1 24 | — | $-6.5M |
| Q4 25 | — | 89.1% | ||
| Q3 25 | — | 89.1% | ||
| Q2 25 | — | 89.3% | ||
| Q1 25 | — | 89.4% | ||
| Q4 24 | — | 89.6% | ||
| Q3 24 | — | 89.4% | ||
| Q2 24 | — | 89.5% | ||
| Q1 24 | — | 89.1% |
| Q4 25 | — | 3.6% | ||
| Q3 25 | — | -4.4% | ||
| Q2 25 | — | -5.9% | ||
| Q1 25 | 70.2% | -10.6% | ||
| Q4 24 | -60.4% | -3.6% | ||
| Q3 24 | — | -2.8% | ||
| Q2 24 | — | 7.6% | ||
| Q1 24 | — | -0.7% |
| Q4 25 | — | -0.7% | ||
| Q3 25 | — | -8.5% | ||
| Q2 25 | — | -8.5% | ||
| Q1 25 | 71.2% | -11.7% | ||
| Q4 24 | -46.4% | -9.7% | ||
| Q3 24 | — | -2.2% | ||
| Q2 24 | — | 5.7% | ||
| Q1 24 | — | -5.3% |
| Q4 25 | — | $-0.03 | ||
| Q3 25 | — | $-0.11 | ||
| Q2 25 | — | $-0.10 | ||
| Q1 25 | $1.90 | $-0.13 | ||
| Q4 24 | $-0.15 | $-0.10 | ||
| Q3 24 | — | $-0.03 | ||
| Q2 24 | — | $0.07 | ||
| Q1 24 | — | $-0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $274.8M | $188.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $350.1M | $-77.2M |
| Total Assets | $406.9M | $569.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $188.0M | ||
| Q3 25 | — | $211.8M | ||
| Q2 25 | — | $203.5M | ||
| Q1 25 | $274.8M | $221.1M | ||
| Q4 24 | $128.0M | $218.4M | ||
| Q3 24 | — | $225.6M | ||
| Q2 24 | — | $271.7M | ||
| Q1 24 | — | $282.5M |
| Q4 25 | — | $-77.2M | ||
| Q3 25 | — | $-76.1M | ||
| Q2 25 | — | $-65.9M | ||
| Q1 25 | $350.1M | $-11.3M | ||
| Q4 24 | $229.0M | $13.4M | ||
| Q3 24 | — | $13.6M | ||
| Q2 24 | — | $24.4M | ||
| Q1 24 | — | $12.7M |
| Q4 25 | — | $569.7M | ||
| Q3 25 | — | $573.6M | ||
| Q2 25 | — | $592.4M | ||
| Q1 25 | $406.9M | $629.4M | ||
| Q4 24 | $271.6M | $664.1M | ||
| Q3 24 | — | $652.0M | ||
| Q2 24 | — | $665.3M | ||
| Q1 24 | — | $662.4M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $131.8M | $7.7M |
| Free Cash FlowOCF − Capex | $131.7M | $7.6M |
| FCF MarginFCF / Revenue | 83.0% | 6.8% |
| Capex IntensityCapex / Revenue | 0.1% | 0.1% |
| Cash ConversionOCF / Net Profit | 1.17× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $9.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $7.7M | ||
| Q3 25 | — | $2.6M | ||
| Q2 25 | — | $10.5M | ||
| Q1 25 | $131.8M | $-9.9M | ||
| Q4 24 | $-23.2M | $12.5M | ||
| Q3 24 | — | $9.3M | ||
| Q2 24 | — | $21.9M | ||
| Q1 24 | — | $2.0M |
| Q4 25 | — | $7.6M | ||
| Q3 25 | — | $2.2M | ||
| Q2 25 | — | $10.2M | ||
| Q1 25 | $131.7M | $-10.2M | ||
| Q4 24 | $-23.2M | $12.0M | ||
| Q3 24 | — | $9.2M | ||
| Q2 24 | — | $21.7M | ||
| Q1 24 | — | $1.9M |
| Q4 25 | — | 6.8% | ||
| Q3 25 | — | 1.9% | ||
| Q2 25 | — | 9.1% | ||
| Q1 25 | 83.0% | -9.3% | ||
| Q4 24 | -102.7% | 10.8% | ||
| Q3 24 | — | 7.8% | ||
| Q2 24 | — | 17.6% | ||
| Q1 24 | — | 1.6% |
| Q4 25 | — | 0.1% | ||
| Q3 25 | — | 0.3% | ||
| Q2 25 | — | 0.3% | ||
| Q1 25 | 0.1% | 0.3% | ||
| Q4 24 | 0.2% | 0.4% | ||
| Q3 24 | — | 0.2% | ||
| Q2 24 | — | 0.1% | ||
| Q1 24 | — | 0.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 1.17× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 3.12× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
STOK
Segment breakdown not available.
ZIP
| License | $84.3M | 75% |
| Services | $27.4M | 25% |
